{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:03:32Z","timestamp":1787313812451,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:00:00Z","timestamp":1559260800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:00:00Z","timestamp":1559260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1038\/s41409-019-0580-7","type":"journal-article","created":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T06:02:51Z","timestamp":1559282571000},"page":"1892-1897","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Safety and efficacy of fresh whole blood donor lymphocyte infusion in children"],"prefix":"10.1038","volume":"54","author":[{"given":"Venkateswaran Vellaichamy","family":"Swaminathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Uppuluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meena","family":"Sivashankaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikila","family":"Ravichandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kesavan Melarcode","family":"Ramanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balasubramaniam","family":"Ramakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshman","family":"Vaidhyanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revathi","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,31]]},"reference":[{"key":"580_CR1","doi-asserted-by":"publisher","first-page":"5824","DOI":"10.1182\/blood-2010-04-282392","volume":"116","author":"RA Marsh","year":"2010","unstructured":"Marsh RA, Vaughn G, Kim MO, Dandan Li, Jodele S, Joshi S, et al. Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation. Blood. 2010;116:5824\u201331.","journal-title":"Blood"},{"key":"580_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/sj.bmt.1703839","volume":"31","author":"C Peters","year":"2003","unstructured":"Peters C, Steward CG. Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines. Bone Marrow Transplant. 2003;31:229\u201339.","journal-title":"Bone Marrow Transplant"},{"key":"580_CR3","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1182\/blood-2005-05-1819","volume":"107","author":"N Cooper","year":"2006","unstructured":"Cooper N, Rao K, Gilmour K, Hadad L, Adams S, Cale C, et al. Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis. Blood. 2006;107:1233\u20136.","journal-title":"Blood"},{"key":"580_CR4","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1182\/blood.V76.12.2462.2462","volume":"76","author":"HJ Kolb","year":"1990","unstructured":"Kolb HJ, Mittermuller J, Clemm C, Holler E, Ledderose G, Brehm G, et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood. 1990;76:2462\u20135.","journal-title":"Blood"},{"key":"580_CR5","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","volume":"86","author":"HJ Kolb","year":"1995","unstructured":"Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European group for blood and marrow transplantation working party chronic leukemia. Blood. 1995;86:2041\u201350.","journal-title":"Blood"},{"key":"580_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1200\/JCO.1997.15.2.433","volume":"15","author":"RH Collins Jr","year":"1997","unstructured":"Collins RH Jr, Shpilberg O, Drobyski WR, Porter DL, Giralt S, Champlin R, et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol. 1997;15:433\u201344.","journal-title":"J Clin Oncol"},{"key":"580_CR7","first-page":"449","volume":"17","author":"HJ Kolb","year":"1996","unstructured":"Kolb HJ, Mittermuller J, Holler E, Thalmeier K, Bartram CR. Graft-versus-host reaction spares normal stem cells in chronic myelogenous leukemia. Bone Marrow Transplant. 1996;17:449\u201352.","journal-title":"Bone Marrow Transplant"},{"key":"580_CR8","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.transci.2016.05.011","volume":"54","author":"L Castagna","year":"2016","unstructured":"Castagna L, Sarina B, Bramanti S, Perseghin P, Mariotti J, Morabito L. Donor lymphocyte infusion after allogeneic stem cell transplantation. Transfus Apher Sci. 2016;54:345\u201355.","journal-title":"Transfus Apher Sci"},{"issue":"9","key":"580_CR9","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1182\/blood-2002-02-0506","volume":"100","author":"D. I. Marks","year":"2002","unstructured":"Mark DI et al. The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation. Blood. 2002;100:3108\u2013114.","journal-title":"Blood"},{"key":"580_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2013.39","volume":"3","author":"P Rujkijyanont","year":"2013","unstructured":"Rujkijyanont P, Morris C, Kang G, Gan K, Hartford C, Triplett B, et al. Risk-adapted donor lymphocyte infusion based on chimerism and donor source in pediatric leukemia. Blood Cancer J. 2013;3:e137.","journal-title":"Blood Cancer J"},{"key":"580_CR11","doi-asserted-by":"publisher","first-page":"288e292","DOI":"10.1016\/j.bbmt.2014.10.010","volume":"21","author":"L Haines","year":"2015","unstructured":"Haines L, Bleesing J, Davies S, Hornung L, Jordan M, Marsh RA, et al. Outcomes of donor lymphocyte infusion for treatment of mixed donor chimerism after a reduced-intensity preparative regimen for pediatric patients with nonmalignant diseases. Biol Blood Marrow Transpl. 2015;21:288e292.","journal-title":"Biol Blood Marrow Transpl"},{"key":"580_CR12","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1016\/j.bbmt.2017.08.038","volume":"23","author":"A Abraham","year":"2017","unstructured":"Abraham A, Hsieh M, Eapen M, Fitzhugh C, Carreras J, Keesler D, et al. Relationship between mixed donor-recipient chimerism and disease recurrence after hematopoietic cell transplantation for sickle cell disease. Biol Blood Marrow Transplant. 2017;23:2178\u201383.","journal-title":"Biol Blood Marrow Transplant"},{"key":"580_CR13","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1182\/bloodadvances.2017007708","volume":"1","author":"CD Fitzhugh","year":"2017","unstructured":"Fitzhugh CD, Walters MC. The case for HLA-identical sibling hematopoietic stem cell transplantation in children with symptomatic sickle cell anemia. Blood Adv. 2017;1:2563\u20137.","journal-title":"Blood Adv"},{"key":"580_CR14","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.bbmt.2014.11.451","volume":"21","author":"B George","year":"2015","unstructured":"George B, Viswabandya A, Abraham A, Sindhuvi E, Ganapule A, Fouzia NA, et al. Increased incidence of mixed chimerism with the use of fludarabine-treosulfan based conditioning in patients undergoing allogeneic stem cell transplantation for thalassaemia major. Biol Blood Marrow Transpl. 2015;21:284\u20135.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"2","key":"580_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/107327480200900205","volume":"9","author":"Leo Luznik","year":"2002","unstructured":"Luznik L et al. Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantation. Cancer Control. 2002;9:123\u201337.","journal-title":"Cancer Control"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0580-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0580-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0580-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:14:54Z","timestamp":1684602894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-019-0580-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,31]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["580"],"URL":"https:\/\/doi.org\/10.1038\/s41409-019-0580-7","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,31]]},"assertion":[{"value":"27 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}